AAnaconda Biomed
Anaconda Biomed is a Barcelona-based (Sant Cugat del Vallès) clinical-stage neurovascular medical device company developing next-generation endovascular access and protection technology to treat acute ischemic stroke caused by large vessel occlusion. Its flagship product, the ANA5 Funnel Catheter, is a self-expanding aspiration thrombectomy device that has received CE Mark and is investigational in the U.S. The company has raised roughly $39-50M across Series A and Series B rounds from European and US life-science investors.
SectorsMedical Devices, Neurovascular, Stroke Care, Healthtech
Start-up MapHealthtech & Bio › Medical devices & surgical hardware
Founders
M
Marc Ribó
Co-Founder (Scientific Advisory Board)
O
Ofir Arad
Co-Founder & Managing Director
Global models 5
IImperative Care
United States · www.imperativecare.com ↗
US neurovascular/thrombectomy platform company developing stroke and venous thromboembolism devices, the largest VC-backed pure-play comparable to Anaconda's stroke thrombectomy focus.
$663MComparable
RRoute 92 Medical
United States · www.route92medical.com ↗
VC-backed developer of aspiration-based mechanical thrombectomy systems for acute ischemic stroke, directly comparable to Anaconda's ANA5 catheter.
$270M+Comparable
E
Endovascular Engineering
United States · www.endovasceng.com ↗
Venture-backed maker of mechanical thrombectomy platforms for peripheral and neurovascular clot removal, same aspiration-thrombectomy device category.
$137MComparable
RRapid Medical
Israel · www.rapid-medical.com ↗
VC-funded neurovascular device maker building stent-retriever and thrombectomy tools for stroke treatment, a close device-category peer.
$80MComparable
NNeuravi
Ireland · www.neuravi.com ↗
VC-backed Irish neurovascular thrombectomy device developer acquired by J&J's Cerenovus, matching Anaconda's stroke-device model and eventual strategic-exit path.
$44.5MComparable
In the same niche 72 others
See all in the Start-ups Map →
Notes: Most funded first
Investors 7
Open as list →
Funding rounds 5
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-09-23 | Series C (estimated) | $56M |
Omega Funds
+4 more
|
| 2025-01-10 | Series B (estimated) | €3.6M |
Lead not disclosed
+3 more
|
| 2019-12-04 | Series B | €20M |
Asabys Partners
+4 more
|
| 2017-05-22 | Series A | €15M |
Ysios Capital, Omega Funds, Innogest Capital
+1 more
|
| 2016-01 | Seed | — | Innogest Capital |
News 3
Open as list →| Published | Article |
|---|---|
| 2026-10-30 |
Beyond the lab: eight European healthtech scaleups taking on medicine's biggest challenges ↗
Tech.eu
2026-10-30 |
| 2026-10-02 |
El ecosistema español supera por primera vez los 1.000M€ de inversión en un mes este septiembre ↗
El Referente
2026-10-02 |
| 2026-09-23 |
Anaconda Biomed raises $56 million with COFIDES joining as an investor. CDTI, Ysios and Asabys also participate ↗
Capital-Riesgo.es
2026-09-23 |